HERENTALS, Belgium, April 1, 2019 /PRNewswire/ -- Kemin Industries, a global ingredient manufacturer focused on improving the quality of life for more than half the world's population, will showcase its new Aleta™ beta glucan (β-glucan) at the Intestinal Health Scientific Interest Group's (IHSIG) 6th Conference on Poultry Intestinal Health in Rome from April 3 – 5, 2019.
The unique beta glucan molecule, derived from the specific algae Euglena gracilis, serves as an immune modulator for all animal species, reinforcing the immune system for optimal function during periods of stress, disease and vaccination.
"Aleta interacts with the immune system, resulting in immune modulation," said Valentine Van Hamme, Product Manager, Kemin Animal Nutrition and Health – EMENA (Europe, Middle East, North Africa). "The immune cells are rapidly recruited and activated to the site of infection, which therefore helps increase the ability for animals to cope with disease and vaccination. Consequently, Aleta will assist animals during periods of stress, disease and vaccination."
In March 2017, Kemin acquired the unique beta glucan manufacturing technology from Algal Scientific and allocated significant resources towards understanding and proving the science behind the molecule. The research showed the algal 1,3 β-glucan can serve as an immune modulator for all animal species, and a new product, Aleta, was launched.
To give this new brand and powerful molecule the attention it deserves, Kemin will host a seminar, "Aleta: The Making of a Hero" on Tuesday, April 2, in Rome before the conference. Topics of discussion will include the importance of the immune system in production animals; the science behind the 1,3 β-glucan molecule; and the benefits to veterinarians and animal health and production stakeholders.
Kemin will also spotlight Aleta during the IHSIG 6th Conference on Poultry Intestinal Health with two abstracts selected for oral presentation. Van Hamme will present, "Algae beta-(1,3)-glucan: its role as an immune modulator" and Natasja Smeets, Innovation Project Leader, Kemin Animal Nutrition and Health – EMENA, will present, "Algae beta-(1,3)-glucan and its role in Infectious Bursal Disease vaccination".
The selection of two Aleta presentations at the conference reflects the strong scientific portfolio Kemin has built around the product. In the past two years, several trials in more than 20 European countries have been conducted, all proving the efficacy of the molecule.
Learn more about the unique Aleta beta glucan on Kemin.com.
About Kemin Industries
Kemin Industries (www.kemin.com) is a global ingredient manufacturer with a focus on improving the quality of life for more than 3.8 billion people every day with over 500 specialty ingredients made for the human and animal health, aquaculture, pet food, nutraceutical, food technology, crop technologies and textile industries.
For over half a century, Kemin has been dedicated to using applied science to address industry challenges and offer product solutions to customers in more than 120 countries. Kemin provides ingredients to feed a growing population with its commitment to the quality, safety and efficacy of food, feed and health-related products.
Established in 1961, Kemin is a privately held, family-owned-and-operated company with more than 2,800 global employees and operations in 90 countries, including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, San Marino, Singapore, South Africa and the United States.
Ester Bolsens, Marketing Communication Manager, firstname.lastname@example.org, 0032 14 242 323
© Kemin Industries, Inc. and its group of companies 2019 All rights reserved. ® ™ Trademarks of Kemin Industries, Inc., U.S.A.
Certain statements, product labeling and claims may differ by geography or as required by government requirements.
SOURCE Kemin Industries